IMA
IMA
NASDAQ · Pharmaceuticals

Imagenebio Inc

$5.83
-0.17 (-2.83%)
Analyst Consensus
Buy
7
Analysts
Moderate
Coverage
Buy 5 71%
Hold 1 14%
Sell 1 14%
Price Target
Analyst Price Target +106.2% upside
Low Target $8.98
Average Target $12.02
High Target $15.27
Current Price $5.83
Current
$5.83
Target
$12.02
$8.98 $12.02 avg $15.27
Scenario Analysis
Bear Case
$8.98
54.0%
Low target
Base Case
$12.02
+106.2%
Avg target
Bull Case
$15.27
+161.9%
High target
Risk/Reward
3.0x
Favorable
Price in Context
52-Week High
$18.00
-67.6% from high
52-Week Low
$3.94
+48.0% from low
Target vs 52W High
$12.02
-33.2% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%